Jerrold F. Rosenbaum

Original Research

Original Research

Original Research

Original Research

Original Research

Original Research

Original Research

Original Research

Original Research

Original Research

Original Research

Original Research

Academic Highlights

Original Research

Academic Highlights

Original Research

Anger Attacks in Patients With Depression

Antecedents to Panic Disorder in Nonreferred Adults.

Attitudes Toward Benzodiazepines Over the Years

Changes in Adverse Events Reported by Patients During 6 Months of Fluoxetine Therapy

Clinical and Demographic Features of Atypical Depression in Outpatients With Major Depressive Disorder: Preliminary Findings From STAR*D.

Clinical Management of Antidepressant Discontinuation

Conclusion

Conclusion/Depression and Its Subtypes: A Treatment Update

Course and Treatment of Atypical Depression

Debate and Discussion: Do Some Antidepressants Have a Faster Onset of Action Than Others?

The Development of Clonazepam as a Psychotropic: The Massachusetts General Hospital Experience

A DIALOGUE

Dopaminergic Agents and Stimulants as Antidepressant Augmentation Strategies

Early Symptomatic Worsening During Treatment With Fluoxetine in Major Depressive Disorder: Prevalence and Implications

Efficacy of Fluvoxamine in the Treatment of Major Depression With Comorbid Anxiety Disorders

Efficacy, Safety, and Gradual Discontinuation of Clonazepam in Panic Disorder: A Placebo-Controlled, Multicenter Study Using Optimized Dosages

An Ideal Trial to Test Differential Onset of Antidepressant Effect

Introduction/Depression and Its Subtypes: A Treatment Update

Introduction: Early Onset of Antidepressant Action

Introduction/Treatment of Panic Disorder: The State of the Art

Partial Response, Nonresponse, and Relapse With Selective Serotonin Reuptake Inhibitors in Major Depression: A Survey of Current "Next-Step" Practices

Possible Biological Mechanisms of the Serotonin Reuptake Inhibitor Discontinuation Syndrome

Predictors of Relapse During Fluoxetine Continuation or Maintenance Treatment of Major Depression

Psychotropic Drug Use During Pregnancy: Weighing the Risks

Residual Symptoms in Depressed Patients Who Respond Acutely to Fluoxetine

Selecting Methodologies for the Evaluation of Differences in Time to Response Between Antidepressants.

Serotonin Reuptake Inhibitor Discontinuation Syndrome: A Hypothetical Definition

Serum Folate, Vitamin B12, and Homocysteine in Major Depressive Disorder, Part 1: Predictors of Clinical Response in Fluoxetine-Resistant Depression

Serum Folate, Vitamin B12, and Homocysteine in Major Depressive Disorder, Part 2: Predictors of Relapse During the Continuation Phase of Pharmacotherapy

Treatment-Resistant Panic Disorder

Utilizing Benzodiazepines in Clinical Practice: An Evidence-Based Discussion.

Ziprasidone Augmentation of Selective Serotonin Reuptake Inhibitors (SSRIs) for SSRI-Resistant Major Depressive Disorder

Benzodiazepines: Revisiting Clinical Issues in Treating Anxiety Disorders

Conclusion: Depression and Its Subtypes: A Treatment Update

Introduction: Depression and Its Subtypes: A Treatment Update

Attitudes Toward Benzodiazepines Over the Years

Course and Treatment of Atypical Depression

The Development of Clonazepam as a Psychotropic: The Massachusetts General Hospital Experience

The History and Current State of Antidepressant Clinical Trial Design: A Call to Action for Proof-of-Concept Studies

In Memoriam: Joseph Biederman, MD

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles